ATN-161 in Advanced Renal Cell Cancer

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2005
The purpose of this study is to determine an active dose of ATN-161 for future studies while establishing preliminary evidence of effectiveness in patients with renal cell cancer.
Epistemonikos ID: 5e51ccf42279e5ca3ee014793494737b417232c5
First added on: May 04, 2024